MedTrace Logo

Lower-Extremity Kinetic Chain Exercise Program for Achilles Tendinopathy

NCT07730866 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-07-28

No results posted yet for this study

Summary

Achilles tendinopathy is a common condition that causes pain, stiffness, and reduced function of the Achilles tendon. It can affect both physically active individuals and the general adult population, often making everyday activities and exercise more difficult. Exercise therapy is widely used as the primary conservative treatment; however, rehabilitation programs that focus only on the Achilles tendon may not address movement impairments involving the entire lower extremity.

This randomized controlled trial will evaluate a rehabilitation program based on the lower-extremity kinetic chain in adults with chronic mid-portion Achilles tendinopathy. Fifty participants will be randomly assigned to receive either a kinetic chain-based exercise program or a conventional rehabilitation program. Assessments will be completed before the intervention begins and again after it is finished.

The study will measure postural stability using the Biodex Balance System, foot and ankle function using the Foot and Ankle Outcome Score (FAOS), pain intensity using the Visual Analog Scale (VAS), and ankle range of motion using a goniometer.

The results will provide information on the effects of a rehabilitation approach that addresses the coordinated function of the lower extremity in people with chronic Achilles tendinopathy.

Conditions

  • Achilles Tendinopathy (AT)

Interventions

BEHAVIORAL

Lower-Extremity Kinetic Chain Exercise Program

The program includes progressive exercises targeting the foot, ankle, knee, hip, and trunk while addressing movement patterns throughout the lower-extremity kinetic chain

BEHAVIORAL

Conventional Exercise Program

A standard rehabilitation program consisting of conventional therapeutic exercises commonly prescribed for chronic Achilles tendinopathy, including tendon-loading and lowe

Sponsors & Collaborators

  • May University in Cairo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-06
Primary Completion
2026-08-02
Completion
2026-08-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07730866 on ClinicalTrials.gov